{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:20:46Z","timestamp":1780456846150,"version":"3.54.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cardiacep.theclinics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiac Electrophysiology Clinics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ccep.2025.10.002","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T23:45:45Z","timestamp":1763336745000},"page":"45-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advances in Antiarrhythmic Drug Therapy"],"prefix":"10.1016","volume":"18","author":[{"given":"Mohammed","family":"Kamareddine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali R.","family":"Keramati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ccep.2025.10.002_bib3","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.jacc.2015.08.856","article-title":"ACC\/AHA\/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"67","author":"Page","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.002_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0735-1097(97)00422-1","article-title":"Paroxysmal supraventricular tachycardia in the general population","volume":"31","author":"Orejarena","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccep.2025.10.002_bib4","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","volume":"41","author":"Brugada","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccep.2025.10.002_bib5","first-page":"449","article-title":"Classification of antiarrhythmic drugs","author":"Vaughan-Williams","year":"1970","journal-title":"Cardiac arrhythmias"},{"key":"10.1016\/j.ccep.2025.10.002_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jpeds.2016.10.051","article-title":"Acute management of refractory and unstable pediatric supraventricular tachycardia","volume":"181","author":"Lewis","year":"2017","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.002_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0196-0644(98)70277-X","article-title":"Comparison of treatment of supraventricular tachycardia by valsalva maneuver and carotid sinus massage","volume":"31","author":"Lim","year":"1998","journal-title":"Ann Emerg Med"},{"issue":"10005","key":"10.1016\/j.ccep.2025.10.002_bib8","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(15)61485-4","article-title":"Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial","volume":"386","author":"Appelboam","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ccep.2025.10.002_bib9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-113-2-104","article-title":"Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil: assessment in placebo-controlled, multicenter trials","volume":"113","author":"DiMarco","year":"1990","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ccep.2025.10.002_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0735-1097(85)80181-9","article-title":"Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias","volume":"6","author":"DiMarco","year":"1985","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.ccep.2025.10.002_bib11","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/01.CIR.0000040587.73251.48","article-title":"Response to adenosine differentiates focal from macroreentrant atrial tachycardia: validation using three-dimensional electroanatomic mapping","volume":"106","author":"Iwai","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccep.2025.10.002_bib12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1460-9592.2002.00477.x","article-title":"Adenosine induced ventricular fibrillation in wolff-parkinson-white syndrome","volume":"25","author":"Gupta","year":"2002","journal-title":"Pacing Clin Electrophysiol"},{"issue":"S2","key":"10.1016\/j.ccep.2025.10.002_bib13","doi-asserted-by":"crossref","first-page":"109S","DOI":"10.1111\/j.1365-2125.1986.tb02860.x","article-title":"The mechanism of action of calcium antagonists relative to their clinical applications","volume":"21","author":"Singh","year":"1986","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.ccep.2025.10.002_bib14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0196-0644(95)70179-6","article-title":"A comparison of adenosine and verapamil for the treatment of supraventricular tachycardia in the prehospital setting","volume":"25","author":"Madsen","year":"1995","journal-title":"Ann Emerg Med"},{"issue":"2","key":"10.1016\/j.ccep.2025.10.002_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0300-9572(01)00459-2","article-title":"Slow-infusion of calcium channel blockers in the emergency management of supraventricular tachycardia","volume":"52","author":"Lim","year":"2002","journal-title":"Resuscitation"},{"issue":"6","key":"10.1016\/j.ccep.2025.10.002_bib16","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1553-2712.1996.tb03467.x","article-title":"Treatment of out-of-hospital supraventricular tachycardia: adenosine vs verapamil","volume":"3","author":"Jr","year":"1996","journal-title":"Acad Emerg Med"},{"issue":"3","key":"10.1016\/j.ccep.2025.10.002_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MEJ.0b013e3283400ba2","article-title":"The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis","volume":"18","author":"Delaney","year":"2011","journal-title":"Eur J Emerg Med"},{"issue":"10","key":"10.1016\/j.ccep.2025.10.002_bib18","first-page":"969","article-title":"Comparison of efficacy of intravenous diltiazem and esmolol in terminating supraventricular tachycardia","volume":"47","author":"Gupta","year":"1999","journal-title":"J Assoc Phys India"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.002_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.CIR.55.1.15","article-title":"Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome","volume":"55","author":"Sellers","year":"1977","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ccep.2025.10.002_bib20","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/01.CIR.94.7.1613","article-title":"Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation","volume":"94","author":"Stambler","year":"1996","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ccep.2025.10.002_bib21","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/hc4101.097538","article-title":"Electrophysiological effects of ibutilide in patients with accessory pathways","volume":"104","author":"Glatter","year":"2001","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ccep.2025.10.002_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0002-9149(96)00566-8","article-title":"Safety and risk\/benefit analysis of ibutilide for acute conversion of atrial fibrillation\/flutter","volume":"78","author":"Kowey","year":"1996","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.ccep.2025.10.002_bib23","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0002-9149(97)00962-4","article-title":"Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias","volume":"81","author":"Clemo","year":"1998","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.ccep.2025.10.002_bib24","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1540-8167.1995.tb00392.x","article-title":"Mechanisms and therapy of complex arrhythmias in pediatric patients","volume":"6","author":"Saul","year":"1995","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"8","key":"10.1016\/j.ccep.2025.10.002_bib25","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/jce.12147","article-title":"The effect of antiarrhythmic medication management on atrial fibrillation ablation outcomes","volume":"24","author":"Dukes","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"4","key":"10.1016\/j.ccep.2025.10.002_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-96-4-409","article-title":"Oral verapamil for paroxysmal supraventricular tachycardia: a long-term, double-blind randomized trial","volume":"96","author":"Mauritson","year":"1982","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.ccep.2025.10.002_bib27","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0002-9149(84)80162-9","article-title":"Long-term therapy of paroxysmal supraventricular tachycardia: a randomized, double-blind comparison of digoxin, propranolol and verapamil","volume":"54","author":"Winniford","year":"1984","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.ccep.2025.10.002_bib28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.7326\/0003-4819-114-7-539","article-title":"Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias: a randomized, placebo-controlled, crossover trial in patients tolerating oral therapy","volume":"114","author":"Pritchett","year":"1991","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.002_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/01.CIR.83.1.119","article-title":"Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group","volume":"83","author":"Henthorn","year":"1991","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ccep.2025.10.002_bib30","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0002-9149(74)90695-X","article-title":"Wolff-Parkinson-White syndrome and atrial fibrillation: relation between refractory period of accessory pathway and ventricular rate during atrial fibrillation","volume":"34","author":"Wellens","year":"1974","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ccep.2025.10.002_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0002-9149(90)90207-H","article-title":"Clinical safety profile of sotalol in patients with arrhythmias","volume":"65","author":"Soyka","year":"1990","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.ccep.2025.10.002_bib32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cpcardiol.2005.06.004","article-title":"Atrial tachycardia: mechanisms, diagnosis, and management","volume":"30","author":"Roberts-Thomson","year":"2005","journal-title":"Curr Probl Cardiol"},{"issue":"9852","key":"10.1016\/j.ccep.2025.10.002_bib33","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(12)61463-9","article-title":"Catheter ablation of atrial arrhythmias: state of the art","volume":"380","author":"Lee","year":"2012","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.ccep.2025.10.002_bib34","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2012.06.031","article-title":"Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation","volume":"60","author":"Cappato","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ccep.2025.10.002_bib35","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0002-8703(85)90458-2","article-title":"Magnesium and potassium therapy in multifocal atrial tachycardia","volume":"110","author":"Iseri","year":"1985","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.002_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00003246-198701000-00004","article-title":"Treatment of multifocal atrial tachycardia with metoprolol","volume":"15","author":"Hazard","year":"1987","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.002_bib37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1540-8167.2005.03272.x","article-title":"Atrioventricular junction ablation and pacemaker therapy in patients with drug-resistant atrial tachyarrhythmias after the Fontan operation","volume":"16","author":"Friedman","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"7","key":"10.1016\/j.ccep.2025.10.002_bib38","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/S0735-1097(00)00635-5","article-title":"Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter","volume":"35","author":"Natale","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.002_bib39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccep.2025.10.002_bib40","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.hrthm.2015.03.029","article-title":"2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope","volume":"12","author":"Sheldon","year":"2015","journal-title":"Heart Rhythm"},{"issue":"12","key":"10.1016\/j.ccep.2025.10.002_bib41","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the cardiac arrhythmia suppression trial","volume":"324","author":"Echt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccep.2025.10.002_bib42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ahj.2021.08.013","article-title":"Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery disease","volume":"243","author":"Burnham","year":"2022","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.ccep.2025.10.002_bib43","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/CIRCULATIONAHA.105.592410","article-title":"Arrhythmias in adult patients with congenital heart disease","volume":"115","author":"Walsh","year":"2007","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ccep.2025.10.002_bib44","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1540-8159.2009.02479.x","article-title":"Dofetilide for atrial arrhythmias in congenital heart disease: a multicenter study","volume":"32","author":"Wells","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"issue":"24","key":"10.1016\/j.ccep.2025.10.002_bib45","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1016\/j.jacc.2017.04.001","article-title":"Heart rate and rhythm and the benefit of beta-blockers in patients with heart failure","volume":"69","author":"Kotecha","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.ccep.2025.10.002_bib46","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1161\/01.CIR.0000132482.95686.87","article-title":"Digoxin in the management of cardiovascular disorders","volume":"109","author":"Gheorghiade","year":"2004","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ccep.2025.10.002_bib47","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM199909163411201","article-title":"Dofetilide in patients with congestive heart failure and left ventricular dysfunction","volume":"341","author":"Torp-Pedersen","year":"1999","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ccep.2025.10.002_bib48","article-title":"Arrhythmias in patients with heart failure prescribed dofetilide or sotalol","volume":"3","author":"Huang","year":"2024","journal-title":"JACC (J Am Coll Cardiol): Advances"},{"issue":"988","key":"10.1016\/j.ccep.2025.10.002_bib49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/hrt.2006.098822","article-title":"Managing palpitations and arrhythmias during pregnancy","volume":"84","author":"Adamson","year":"2008","journal-title":"Postgrad Med J"},{"issue":"7","key":"10.1016\/j.ccep.2025.10.002_bib50","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9149(99)80597-9","article-title":"Adenosine therapy for supraventricular tachycardia during pregnancy","volume":"75","author":"Elkayam","year":"1995","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.ccep.2025.10.002_bib51","article-title":"Oral beta-blockers for mild to moderate hypertension during pregnancy","volume":"2012","author":"Magee","year":"1996","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.ccep.2025.10.002_bib52","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.jp.7211104","article-title":"Amiodarone-induced neonatal hypothyroidism: a unique form of transient early-onset hypothyroidism","volume":"24","author":"Lomenick","year":"2004","journal-title":"J Perinatol"},{"issue":"6","key":"10.1016\/j.ccep.2025.10.002_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/jce.12675","article-title":"Catheter ablation of arrhythmia during pregnancy","volume":"26","author":"Driver","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"18_suppl_2","key":"10.1016\/j.ccep.2025.10.002_bib54","doi-asserted-by":"crossref","first-page":"S526","DOI":"10.1161\/CIR.0000000000000266","article-title":"Part 12: pediatric advanced life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care","volume":"132","author":"De Caen","year":"2015","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ccep.2025.10.002_bib55","first-page":"984","article-title":"The study of antiarrhythmic medications in infancy (SAMIS) a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants","volume":"5","author":"Sanatani","year":"2012","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ccep.2025.10.002_bib56","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1540-8167.1995.tb00376.x","article-title":"Independent autonomic modulation of the human sinus and AV nodes: evidence from beat-to-beat measurements of PR and PP intervals during sleep","volume":"6","author":"Kowallik","year":"1995","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"6","key":"10.1016\/j.ccep.2025.10.002_bib57","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0002-9149(97)00521-3","article-title":"Lack of effect of estrogen on rest and treadmill exercise in postmenopausal women without known cardiac disease","volume":"80","author":"Lee","year":"1997","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.ccep.2025.10.002_bib58","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/0003-4819-137-9-200211050-00035","article-title":"Cardioselective \u03b2-blockers in patients with reactive airway disease: a meta-analysis","volume":"137","author":"Salpeter","year":"2002","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.002_bib59","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/01.CIR.82.1.51","article-title":"Clinical features of amiodarone-induced pulmonary toxicity","volume":"82","author":"Dusman","year":"1990","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.002_bib60","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrendo.2009.225","article-title":"Effects of amiodarone therapy on thyroid function","volume":"6","author":"Cohen-Lehman","year":"2010","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"10.1016\/j.ccep.2025.10.002_bib61","first-page":"639","article-title":"Multicenter, phase 2, randomized controlled study of the efficacy and safety of etripamil nasal spray for the acute reduction of rapid ventricular rate in patients with symptomatic atrial fibrillation (ReVeRA-201)","volume":"16","author":"Camm","year":"2023","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ccep.2025.10.002_bib62","article-title":"First randomized, multicenter, placebo-controlled study of self-administered intranasal etripamil for acute conversion of spontaneous paroxysmal supraventricular tachycardia (NODE-301)","volume":"15","author":"Stambler","year":"2022","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.ccep.2025.10.002_bib63","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028227","article-title":"Etripamil nasal spray for conversion of repeated spontaneous episodes of paroxysmal supraventricular tachycardia during long-term follow-up: results from the NODE-302 study","volume":"12","author":"Ip","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.ccep.2025.10.002_bib64","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0735-1097(03)00987-2","article-title":"Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist","volume":"42","author":"Prystowsky","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ccep.2025.10.002_bib65","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0735-1097(00)01128-1","article-title":"Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia","volume":"37","author":"Alboni","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ccep.2025.10.002_bib66","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/europace\/euz175","article-title":"Vernakalant for cardioversion of recent-onset atrial fibrillation: a systematic review and meta-analysis","volume":"21","author":"McIntyre","year":"2019","journal-title":"EP Europace"},{"issue":"9","key":"10.1016\/j.ccep.2025.10.002_bib67","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2014.12.026","article-title":"Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation","volume":"65","author":"Stavrakis","year":"2015","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiac Electrophysiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918225000760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918225000760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T20:39:38Z","timestamp":1769546378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877918225000760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1877918225000760"],"URL":"https:\/\/doi.org\/10.1016\/j.ccep.2025.10.002","relation":{},"ISSN":["1877-9182"],"issn-type":[{"value":"1877-9182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Antiarrhythmic Drug Therapy","name":"articletitle","label":"Article Title"},{"value":"Cardiac Electrophysiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccep.2025.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}